Home Meetings Online CME/CE Clinical Resources EHR/EMR
Advertisement

Topics above reflect online activities only. See our Live Meeting programs for more topics.

 

Pediatrics News

Text Size: Choose Text Size
Bookmark and Share  
  • Thursday, July 24, 2014
    Journal
    Prenatal Maternal Smoking Ups Risk of ADHD in Offspring

    Similar association found for women who use nicotine replacement during pregnancy



    Maternal smoking and nicotine replacement therapy during pregnancy are associated with increased risk of attention-deficit/hyperactivity disorder in children, according to research published online July 21 in Pediatrics.

    THURSDAY, July 24, 2014 (HealthDay News) -- Maternal smoking and nicotine replacement therapy during pregnancy are associated with increased risk of attention-deficit/hyperactivity disorder (ADHD) in children, according to research published online July 21 in Pediatrics.

    Jin Liang Zhu, Ph.D., of Aarhus University in Denmark, and colleagues used data from 84,803 women with single births to assess the effects of maternal smoking and nicotine replacement use during pregnancy on the risk of ADHD in the child. The association between risk of ADHD in the child and paternal smoking was used as a potential confounder.

    The researchers found that both maternal and paternal smoking during pregnancy were associated with increased risk of ADHD, but the association was stronger for maternal rather than paternal smoking. Children born of smoking mothers and nonsmoking fathers, compared with children born of nonsmoking mothers and smoking fathers, had a greater risk of ADHD (adjusted hazard ratio, 1.26; 95 percent confidence interval, 1.03 to 1.53). Children of mothers who used nicotine replacement during pregnancy also had a greater risk of ADHD.

    "In conclusion, our findings suggest that exposure to prenatal tobacco smoke, possibly nicotine, may have a prenatal programming effect on the risk of ADHD in children," the authors write.

    Abstract
    Full Text

 View All Medical News

Company
Exhibitors
Support
Terms
Tel: (877) 477-4633